Epigenetic reader domain inhibitor Bromosporine, Purity ≥98%

Synonym: 1619994-69-2; Bromosporine; Ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-yl)carbamate; CHEMBL3133807; Epigenetic reader domain inhibitor

CAS Number: 1619994-69-2
Compound CID: 72943187

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Bromosporine, soluble in DMSO and insoluble in ethanol and water, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.

Molecular Weight

404.44

Molecular Formula

C₁₇H₂₀N₆O₄S

Form

Lyophilized powder

Purity

≥98%

Solubility

DMSO: 77 mg/mL (190.38 mM); Water: Insoluble; Ethanol: Insoluble

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

Bromosporine can be used as a broad-spectrum bromodomain inhibitor to understand the role of these domains in chromatin biology and disease.

Storage

Store at -20ºC.